Healthcare Global Enterprises share price
NSE: HCGBSE: 539787Healthcare ServicesSmall Cap
Healthcare Global Enterprises Limited · Face value ₹10 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Mar 2016 · Issue price ₹218
Last close ₹591.45up ₹5.85 (1.00%)BSE ₹591.25
Share price at the NSE close on 29 Oct 2026. Previous close ₹585.60.
29 Oct: open ₹586.30, high ₹594.65, low ₹581.65
52-week range of traded prices to 29 Oct 2026
₹513.30Low, 30 Mar 2026₹803.95High, 29 Oct 2025
- Next results date: the board meets on 5 Nov 2026 to consider: financial results. The notice · Results calendar
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹8,830 Cr593rd largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 387.64
- P/E without one-offsPrice to earnings without one-off items. Market cap divided by core profit: the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, less one-off items (exceptional items and the result of businesses sold or closed). Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes −₹45 crore of one-off items, the largest of them in the quarter to Mar 2026.
- 131.09
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 6.63
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 2.0%
- ROE without one-offsReturn on equity without one-off items. Core profit, the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders less one-off items (exceptional items and the result of businesses sold or closed), as a percentage of the same net worth as the return on equity. Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes −₹45 crore of one-off items, the largest of them in the quarter to Mar 2026.
- 6.0%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 9.6%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.65
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 51,70749.3% delivered
Results
Consolidated; ₹ crore.Healthcare Global Enterprises quarterly results
- Revenue growth, 12 monthsRevenue growth, 12 months. The last twelve months against the twelve before them. Left empty where the earlier figure was nought or a loss: growth out of a loss has no percentage.
- +13.8%
- Net profit growth, 12 monthsNet profit growth, 12 months. The last twelve months against the twelve before them. Left empty where the earlier figure was nought or a loss: growth out of a loss has no percentage.
- −38.6%
Quarter to Jun 2026, against the quarter before
- RevenueRevenue. The pill is the change in revenue against the quarter before: this period's figure divided by that one's, less one, in per cent.
- ₹695 Crup 6.56%
- Net profitNet profit. The pill is the change in net profit against the quarter before: this period's figure divided by that one's, less one, in per cent. Net profit in the glossary
- ₹16 Crup 307.43%
- Net marginNet margin. Net profit as a percentage of revenue: how much of each rupee of sales is left after every cost, interest and tax. Net margin in the glossary
- 2.4%
Revenue by quarter
Peak revenue ₹695 Cr, quarter to Jun 2026; lowest ₹554 Cr, quarter to Sep 2024
Net profit by quarter, a loss in red
- Net profit
- Loss
A loss in 1 of the 8 quarters shown
| ₹ crore | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 554 | 558 | 585 | 613 | 647 | 633 | 652 | 695 |
| Net profit | 21 | 8 | 7 | 6 | 21 | −8 | 4 | 16 |
| Net margin | 3.7% | 1.4% | 1.2% | 1.0% | 3.2% | −1.2% | 0.6% | 2.4% |
Consolidated. The last eight quarters. The latest is shaded. Net profit is the whole group's, the other owners of its subsidiaries included; P/E and ROE use the company's own share.
Year to Mar 2026, against the year before
- RevenueRevenue. The pill is the change in revenue against the year before: this period's figure divided by that one's, less one, in per cent.
- ₹2,545 Crup 14.51%
- Net profitNet profit. The pill is the change in net profit against the year before: this period's figure divided by that one's, less one, in per cent.
- ₹23 Crdown 53.35%
- Net margin
- 0.9%
Revenue by year
Peak revenue ₹2,545 Cr, year to Mar 2026; lowest ₹700 Cr, year to Mar 2017
Net profit by year, a loss in red
- Net profit
- Loss
A loss in 3 of the 10 years shown
| ₹ crore | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 700 | 831 | 976 | 1,096 | 1,013 | 1,398 | 1,694 | 1,912 | 2,223 | 2,545 |
| Net profit | 23 | 17 | −31 | −125 | −221 | 39 | 18 | 41 | 49 | 23 |
| Net margin | 3.3% | 2.0% | −3.2% | −11.4% | −21.8% | 2.8% | 1.0% | 2.2% | 2.2% | 0.9% |
Consolidated. Years to March. The latest is shaded. Net profit is the whole group's, the other owners of its subsidiaries included; P/E and ROE use the company's own share.
Business segments
In the year to Mar 2026 the company reports one business segment, Healthcare, which carries all its revenue.
Valuation
Today, against the company's own history. Dividend yield is not shown: no dividend in the years on record.Healthcare Global Enterprises PE ratio and valuation
Price to earnings
At or below today's level on 29% of 903 trading days over the last 5 years.
LowestHighest
Its median144.15Industry median42.76
Price to book
At or below today's level on 74% of 1,792 trading days since Nov 2018.
LowestHighest
Its median4.48Industry median4.45
Where the return came from
Yearly rates to Mar 2026, per-share figures restated for splits and bonuses.
| Over | Return a year | Earnings growth | Change in P/E | Dividend yield |
|---|---|---|---|---|
| 1 year | −3.1% | −69.6% | +218.6% | 0.0% |
| 3 years | +26.0% | −22.8% | +63.3% | 0.0% |
| 5 years | +22.5% | – | – | 0.0% |
Return is price growth plus the average dividend yield. Change in P/E is (1 + price growth) / (1 + earnings growth) - 1, so the parts compound rather than add. Earnings growth and the change in P/E are left empty where earnings per share at either end of the window was a loss or is not on record. Earnings growth over 5 years is on profit divided by shares in issue at both ends: the earnings per share stated for one end does not match that year's profit and share count. Earnings growth over 1 and 3 years includes one-off items (exceptional items and the result of businesses sold or closed) of more than a tenth of the profit of the year to Mar 2026.
Mutual fund holdings
40 funds disclosed a holding for Sep 2026. What they did in Sep 2026, against each fund's month before. 10 of the 16 funds that added or cut are index funds, ETFs or arbitrage funds: an index fund or ETF holds what its index holds, and an arbitrage fund holds the share against a sale of its future.All 40 funds holding Healthcare Global Enterprises
- Bought for the first timeBought for the first time. Funds that held it at the month's end and had not held it in any month on record before.
- 2
- AddedAdded. Funds that held more shares than at the end of the month before.
- 9
- CutCut. Funds that held fewer shares than at the end of the month before.
- 7
- Held unchangedHeld unchanged. Funds that held the same number of shares as at the end of the month before.
- 22
- Sold outSold out. Funds that held it at the end of the month before and hold none at this month's end. Sold out in the glossary
- 2
| Fund | |||
|---|---|---|---|
 Nippon India Small Cap FundNippon India Mutual Fund | 46,58,823 | 0.38% | ₹310.3 Cr |
| Nippon India ELSS Tax Saver FundNippon India Mutual Fund | 37,05,882 | 1.75% | ₹246.8 Cr |
 Axis Small Cap FundAxis Mutual Fund | 32,73,271 | 0.71% | ₹218.0 Cr |
 Franklin India Small Cap FundFranklin Templeton Mutual Fund | 20,66,305 | 0.97% | ₹137.6 Cr |
| Axis Flexi Cap FundAxis Mutual Fund | 15,86,026 | 0.80% | ₹105.6 Cr |
 SBI Healthcare Opportunities FundSBI Mutual Fund | 15,00,000 | 1.70% | ₹99.9 Cr |
 Tata India Pharma & Healthcare FundTata Mutual Fund | 13,44,012 | 5.92% | ₹89.5 Cr |
| Tata Focused FundTata Mutual Fund | 10,08,833 | 4.14% | ₹67.2 Cr |
| Tata Aggressive Hybrid FundTata Mutual Fund | 10,00,000 | 1.67% | ₹66.6 Cr |
| Axis Multicap FundAxis Mutual Fund | 9,77,588 | 0.54% | ₹65.1 Cr |
Portfolios disclosed for Sep 2026. Weight is the holding as a share of the fund's assets.
Promoter and insider buying and selling
Trades made since 30 Oct 2025.Healthcare Global Enterprises insider trading
Bought on the marketBought on the market. The value each filer stated for its purchases on the exchange, added up; gifts, transfers and pledges are not counted. A purchase filed with no value is counted under the sum, not in it. Sold on the marketSold on the market. The value each filer stated for its sales on the exchange, added up; gifts, transfers and pledges are not counted. A sale filed with no value is counted under the sum, not in it.
- Employees0 purchases, 4 salesNo purchase₹3.66 CrNetNet. The value bought on the market less the value sold, over the trades whose filers stated a value.−₹3.66 Cr1 pledge created · 2 pledges released · 5 pledges invoked by a lender · 1 off-market move
- Others0 purchases, 4 salesNo purchase₹0.46 CrNet−₹0.46 Cr1 pledge created · 1 pledge released · 3 pledges invoked by a lender · 1 pledge filing of unclear kind
- Promoters and promoter group: no market trade · 7 off-market moves
Bought and sold count trades on the market only. A pledge is shares given to a lender as security for a loan; a lender invokes it by selling them.
Healthcare Global Enterprises competitors and peers
Hospital, 40 listed companies, priced on 29 Oct 2026. The table lists the 8 companies closest to Healthcare Global Enterprises in market cap.Healthcare companies
Where the company sits among the companies nearest its size
| Company | ||||||||
|---|---|---|---|---|---|---|---|---|
 Dr. Agarwal's Health CareAGARWALEYE | 15,493 | 104.42 | 7.65 | – | – | 7.6% | 14.1% | 0.00% |
 Rainbow Childrens MedicareRAINBOW | 12,155 | 42.59 | 7.38 | +18.3% | +10.9% | 18.3% | 25.0% | 0.29% |
 Park Medi WorldPARKHOSPS | 9,556 | – | 4.73 | – | – | – | – | 0.00% |
 Yatharth Hospital & Trauma Care ServicesYATHARTH | 8,896 | 49.88 | 4.92 | +44.0% | – | 10.5% | 10.2% | 0.05% |
 Jupiter Life Line HospitalsJLHL | 8,527 | – | 5.23 | +16.3% | – | – | 11.7% | 0.08% |
| Paras HealthcarePARASHLTH | 8,387 | – | – | – | – | – | – | 0.00% |
 Kovai Medical Center & HospitalKOVAI | 6,452 | 25.17 | 4.89 | +15.0% | +16.3% | 21.3% | 20.3% | 0.25% |
 Artemis Medicare ServicesARTEMISMED | 4,717 | 41.50 | 5.05 | +15.0% | +30.3% | 12.8% | 13.2% | 0.15% |
Market cap in ₹ crore. Growth is the last twelve months against the twelve before. A figure is left empty where it would rest on a loss or the company has under a year of results on record. ROE is the shareholders' profit over their net worth. ROCE is profit before interest and tax over the whole group's net worth plus borrowings, as in the figures at the top of the page.
Latest announcements
Routine notices left out.Healthcare Global Enterprises announcements
Oct 2026
Sep 2026
18 Sep · Meeting
17 Sep · Analysts
Healthcare Global Enterprises annual report, year to Mar 2026
Healthcare Global Enterprises share price by year
Each calendar year to 2025.Healthcare Global Enterprises share price history
| Year | Close at year end | Change | Highest close | Lowest close |
|---|---|---|---|---|
| 2025 | 662.00 | +35.3% | 776.30 | 471.70 |
| 2024 | 489.15 | +33.8% | 542.40 | 315.20 |
| 2023 | 365.50 | +27.2% | 378.95 | 258.10 |
| 2022 | 287.45 | +20.2% | 314.50 | 225.20 |
| 2021 | 239.05 | +46.9% | 267.90 | 150.40 |
| 2020 | 162.75 | +55.9% | 171.95 | 66.25 |
| 2019 | 104.40 | −46.6% | 220.00 | 92.00 |
| 2018 | 195.55 | −30.1% | 338.10 | 194.20 |
| 2017 | 279.80 | +13.1% | 298.40 | 220.15 |
| 2016 | 247.50 | – | 257.85 | 171.00 |
₹ per share, adjusted for splits and bonuses since. Change is on the close at the end of the year before. 2016 is from its first session, 30 Mar 2016.
Recent sessions
The 9 trading days to 28 Oct 2026, as traded on NSE; the latest is at the top of the page.
| Date | Open | High | Low | Close | Average price | Volume | Delivery |
|---|---|---|---|---|---|---|---|
| 28 Oct 2026 | 592.00 | 598.60 | 578.05 | 585.60 | 589.99 | 65,390 | 47.3% |
| 27 Oct 2026 | 564.00 | 592.90 | 564.00 | 589.25 | 585.19 | 1,28,512 | 60.2% |
| 26 Oct 2026 | 545.05 | 573.25 | 543.70 | 569.85 | 562.20 | 70,619 | 62.6% |
| 23 Oct 2026 | 550.00 | 555.45 | 538.65 | 549.65 | 548.22 | 1,11,097 | 52.3% |
| 22 Oct 2026 | 549.00 | 561.30 | 541.45 | 550.65 | 550.74 | 2,47,059 | 77.3% |
| 21 Oct 2026 | 568.00 | 571.50 | 545.90 | 550.10 | 553.22 | 88,799 | 56.6% |
| 19 Oct 2026 | 583.05 | 586.80 | 568.00 | 569.70 | 575.32 | 85,212 | 49.1% |
| 16 Oct 2026 | 594.80 | 594.80 | 578.25 | 588.20 | 583.42 | 1,51,171 | 58.0% |
| 15 Oct 2026 | 592.00 | 595.05 | 586.50 | 590.60 | 590.53 | 2,09,013 | 80.4% |
Prices in ₹ per share as traded, not adjusted.
Price adjustments
What the price chart is corrected for, so it reads as one share held throughout.Rights issue and open offer history
| Ex-date | Event | Price factor | What happened |
|---|---|---|---|
| 2 Mar 2026 | Rights issue | – | Shareholders were offered new shares. Noted, not adjusted for. |
Each event is noted and not adjusted for.
Company details
- NSE symbol
- HCG
- BSE code
- 539787
- ISIN
- INE075I01017
- Industry
- Healthcare Services
- Website
- www.hcgel.com
- CIN
- L15200KA1998PLC023489
- Corporate identity number, the registrar of companies' code for it
- Incorporated
- 1998
- Registered office
- HCG Tower, No. 8, P Kalinga Rao Road, Sampangi Rama Nagar, Bengaluru 560027, Karnataka
- Share registrar
- KFin Technologies Ltd
- Keeps the register of shareholders and handles transfers and dividend payments